2014 ACR/ARHP Annual Meeting Archives

Abstract Number: 297

S100 Proteins in Oligoarticular Juvenile Idiopathic Arthritis
Abstract Number: 2948

S100 Proteins Induce Canonical Wnt Signaling, Which Causes Increased Expression of MMPs in the Synovium
Abstract Number: 2952

S100A9 Inhibitor Paquinimod (ABR-215757) reduces Joint Destruction in Experimental Osteoarthritis and Blocks Activating Effects of S100A9 in OA Synovium
Abstract Number: 2764

S100B Astrocyte Protein May Serve As a Prognostic Factor in Reversible Cerebral Vasoconstrictive Syndromes
Abstract Number: 1895

Sacroiliitis at Diagnosis in Children with Juvenile Spondyloarthritis
Abstract Number: 2822

Safety and Efficacy of Baricitinib through 128 Weeks in an Open-Label, Long-Term Extension Study in Patients with Rheumatoid Arthritis
Abstract Number: 852

Safety and Efficacy of Certolizumab Pegol over 96 Weeks in Patients with Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis
Abstract Number: 949

Safety and Efficacy of CF101 in Rheumatoid Arthritis Patients: A Phase II Study
Abstract Number: 2234

Safety and Efficacy of Liposome Intra-Articular Injection in Moderate Knee Osteoarthritis. a Prospective Randomized Double-Blinded Study
Abstract Number: 8

Safety and Efficacy of New Oral Direct Inhibitors of Thrombin and Factor Xa in Antiphospholipid Syndrome
Abstract Number: 2285

Safety and Efficacy of Rilonacept in Patients with Deficiency of Interleukin-1 Receptor Antagonist (DIRA)
Abstract Number: 1297

Safety and Efficacy of Rituximab in Pediatric Lupus and Other Rheumatic Diseases
Abstract Number: L4

Safety and Efficacy of Sifalimumab, an Anti IFN-Alpha Monoclonal Antibody, in a Phase 2b Study of Moderate to Severe Systemic Lupus Erythematosus (SLE)
Abstract Number: 874

Safety and Efficacy of Subcutaneous Tocilizumab in Adults with Systemic Sclerosis: Week 24 Data from a Phase 2/3 Trial
Abstract Number: 665

Safety and Efficiency of Low-Dose Interleukin-2 Treatment in Systemic Lupus Erythematosus
Abstract Number: 1492

Safety and Tolerability of NNC01140006, an Anti-IL-21 Monoclonal Antibody, at Multiple s.c. Dose Levels in Patients with Rheumatoid Arthritis
Abstract Number: 718

Safety of Gardasil® Vaccine in Systemic Lupus Erythematosu, Trial Update
Abstract Number: 2376

Safety of Rapid Rituximab Infusion in Rheumatoid Arthritis in a Single Community Practice
Abstract Number: 469

Safety of Rituximab in Patients with Chronic Inflammatory Arthritis. Seven-Year Follow-up Observational Study
Abstract Number: 1319

Safety of Rituximab in Treating Pediatric Rheumatologic Disease
Abstract Number: 243

Safety of Solumatrix Diclofenac in Adults with Osteoarthritis: Results of a 12-Month, Phase 3 Study
Abstract Number: 847

Safety of TNF Inhibitor Therapy in Patients Who Have Had a Prior Malignancy
Abstract Number: 1836

Safety of Zoster Vaccination Administration in Rheumatic Patients on Current Biologic Therapy
Abstract Number: 470

Safety Profile of Biologic Agents for Rheumatoid Arhtisitis Treatment after the Complication with Methotrexate-Related Lymphoproliferative Disorder
Abstract Number: 951

Safety, Tolerability, and Functional Activity of ABT-122, a Dual TNF- and IL-17A–Targeted DVD-Ig™, Following Single-Dose Administration in Healthy Subjects
Abstract Number: 527

Salivary Expression of S100A7/Psoriasin and Oral Damage in Primary Sjögren’s Syndrome and Overlapping Disorders
Abstract Number: 347

Salt Aggravates Arthritis By Th17 Polarization
Abstract Number: 876

SAR100842, an Antagonist of Lysophaphatidic Acid Receptor 1, As a Potential Treatment for Patients with Systemic Sclerosis: Results from a Phase 2a Study
Abstract Number: 1412

Sarcopenia and Its Impact on Disability in Rheumatoid Arthritis, a Pilot Study
Abstract Number: 735

Sarcopenia in Systemic Sclerosis: Prevalence and Association with Functional Parameters and Quality of Life
Abstract Number: 2862

Satisfaction Following Total Knee Replacement: Journey or Destination?
Abstract Number: 1156

Satisfaction with Rural Rheumatology Telehealth Service
Abstract Number: 1187

Scoring of Spinal Lesions Compatible with Axial Spondyloarthritis on MRI in Clinical Practice By Local Radiologist or Rheumatologist in Desir; Comparison with Central Reading
Abstract Number: 1425

Screening Behavior and Prevalence of Hepatitis C Virus in Mexico
Abstract Number: 2998

Screening for Interstitial Lung Disease in Systemic Sclerosis: Performance of High-Resolution Computed Tomography with Limited Number of Slices – a Prospective Study
Abstract Number: 1583

Screening for Psa in Primary Care Psoriasis Patients with Musculoskeletal Complaints with PEST, PASE & Earp
Abstract Number: 2429

Seasonal Changes May Influence Activity of Rheumatoid Arthritis
Abstract Number: 568

Secondary Amyloidosis Complicating Spondyloarthritis: Still Present after All These Years
Abstract Number: L1

Secukinumab, a Human Anti-Interleukin-17A Monoclonal Antibody, Improves Active Psoriatic Arthritis: 24-Week Efficacy and Safety Data from a Phase 3 Randomized, Multicenter, Double-Blind, Placebo-Controlled Study Using Subcutaneous Dosing
Abstract Number: 953

Secukinumab, a Human Anti–Interleukin-17A Monoclonal Antibody, Improves Active Psoriatic Arthritis and Inhibits Radiographic Progression: Efficacy and Safety Data from a Phase 3 Randomized, Multicenter, Double-Blind, Placebo-Controlled Study
Abstract Number: 537

Secukinumab, a Human Anti–Interleukin-17A Monoclonal Antibody, Significantly Reduces Psoriasis Burden in Patients with Psoriatic Arthritis: Results from a Phase 3 Randomized Controlled Trial
Abstract Number: 954

Secukinumab, a Monoclonal Antibody to Interleukin-17A, Provides Significant and Sustained Inhibition of Joint Structural Damage in Active Psoriatic Arthritis Regardless of Prior TNF Inhibitors or Concomitant Methotrexate: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study
Abstract Number: 538

Secukinumab, a Monoclonal Antibody to Interleukin-17A, Significantly Improves Physical Function and Quality of Life in Subjects with Active Ankylosing Spondylitis: Results of a Phase 3 Randomized, Placebo-Controlled Trial with Intravenous Loading and Subcutaneous Maintenance Dosing
Abstract Number: 819

Secukinumab, a Monoclonal Antibody to Interleukin-17A, Significantly Improves Signs and Symptoms of Active Ankylosing Spondylitis: Results of a 52-Week Phase 3 Randomized Placebo-Controlled Trial with Intravenous Loading and Subcutaneous Maintenance Dosing
Abstract Number: 536

Secukinumab, a Monoclonal Antibody to Interleukin-17A, Significantly Improves Signs and Symptoms of Active Ankylosing Spondylitis: Results of a Phase 3, Randomized, Placebo-Controlled Trial with Subcutaneous Loading and Maintenance Dosing
Abstract Number: 550

Secukinumab, an Anti–Interleukin-17A Monoclonal Antibody, Improves Physical Function, Quality of Life and Work Productivity in Patients with Active Psoriatic Arthritis: Results from a Phase 3, Randomized, Controlled Trial
Abstract Number: 2944

Sedentary Time Is an Independent Risk Factor for Disability Onset Among Adults at Elevated Risk: Prospective Cohort Study
Abstract Number: 1513

Selection of Vagus Nerve Stimulation Parameters for a First-in-Human Study in Rheumatoid Arthritis: A Unique Translational Medicine Challenge
Abstract Number: 267

Selective and Peripheral-Specific Trk Inhibitor Shows Potent Analgesic Effect Comparable to Morphine in Rat Osteoarthritis Model without CNS Toxicity
Abstract Number: 2184

Selective Consumption of C2 Component in HCV Patients
Abstract Number: 391

Self-Assessment Tool of Rheumatoid Arthritis Disease Activity: Handgrip Strength Measured By a Smartphone Connected to a Dynamometer
Abstract Number: 173

Self-Management Education for Patients with Gout: A Review of Existing Resources
Abstract Number: 2164

Self-Phospholipids Regulate Inflammation Via Activation of CD1d-Restricted T-cells and Induction of ‘anti-inflammatory’ Myeloid-Derived Suppressor Cells (MDSC)
Abstract Number: 2663

Sense of Smell, Anti-Ribosomal P Antibodies and Neuropsychiatric Manifestations in Systemic Lupus Erythematosus
Abstract Number: 2142

Sensitivity and Precision of Automated Osteophyte Volumetric Measurement in Knee Osteoarthritis over Four Years
Abstract Number: 2129

Sensitivity and Specificity of the “Green Nail” Sign in Fluorescence Optical Imaging in Psoriatic Arthritis
Abstract Number: 353

Sensitivity of Unique Multidimensional Health Assessment Questionnaire Items Compared to Items on Both the HAQ and MDHAQ in Patients with RA and SLE
Abstract Number: 2141

Sensitivity to Change of Joint Space Width Measurements in Hand Osteoarthritis in a Two Year Follow-up Study
Abstract Number: 1284

Sensitivity to Change of Patient Preference Outcome Measures for Pain in Trials of Patients with Knee Osteoarthritis
Abstract Number: 2682

Serine Arginine-Rich Splicing Factor 1 (SRSF1) Regulates Transcriptional Activation of the T Cell Receptor CD3 Zeta Chain in Human T Cells
Abstract Number: 1851

Serious Infection Events in the Psoriasis Longitudinal Assessment and Registry Study: Cumulative Experience
Abstract Number: 480

Serious Infection Risk By Treatments and Types in Patients with RA
Abstract Number: 825

Serious Infections on TNF Inhibitors: Have the Risks Changed over Calendar Time, and How High Are They?
Abstract Number: 1248

Serologic and Clinical Overlap Between Sarcoidosis and the Rheumatic Autoimmume Diseases
Abstract Number: 887

Serological and Clinical Characteristics of a Large Collection of Incomplete Lupus Erythematosus Patients
Abstract Number: 407

Serum 14-3-3η Protein Supplements Traditional Rheumatoid Arthritis Biomarkers
Abstract Number: 2212

Serum Adipokines in Dermatomyositis: Correlation with Risk Factors Associated to Cardiovascular Diseases and Metabolic Syndrome
Abstract Number: 1639

Serum Anti-Müllerian Hormone Levels in SLE Patients. the Disease Severity and Cyclophosphamide Reduce the Ovarian Reserve
Abstract Number: 2601

Serum Biomarkers Associated with Changes in ASDAS and MRI Following Treatment of Ankylosing Spondylitis with Golimumab
Abstract Number: 534

Serum Biomarkers of Inflammation and Fibrosis in Advancing Diagnosis, Prognosis and Treatment of Anti-Ro Associated Congenital Heart Block
Abstract Number: 2099

Serum C-X-C Motif Chemokine 10 (CXCL10) Is Elevated in Psoriasis Patients Prior to Psoriatic Arthritis Onset
Abstract Number: 368

Serum C1M Level Predicts Disease Progression and Early Treatment Efficacy in Rheumatoid Arthritis
Abstract Number: 136

Serum Calprotectin (S100A8/9) Is an Independent Predictor of Ultrasound Synovitis in Patients with Rheumatoid Arthritis
Abstract Number: 1860

Serum Calprotectin and Disease Relapse in ANCA-Associated Vasculitis
Abstract Number: 988

Serum CXCL13 As a Biomarker of Disease Activity and Severity in Rheumatoid Arthritis: Comparison with Acute Phase Reactants and the Autoantibody Profile
Abstract Number: 523

Serum CXCL4 Is Increased in Patients with Primary Sjögren’s Syndrome and Is Associated with Features of Microvascular Impairment
Abstract Number: 1653

Serum Cystatin C As a Biomarker for Clinical Practice in Patients with Lupus Nephritis
Abstract Number: 807

Serum Cytokine Profiles in Takayasu’s Arteritis: A Search for a Biomarker
Abstract Number: 1598

Serum Fetuin-a, Intercellular Adhesion Molecule -1 and Interleukin -18 Levels in Ankylosing Spondylitis and Psoriatic Arthritis
Abstract Number: 736

Serum Galectin-3 Levels in Early Diffuse Systemic Sclerosis and the Relationship to Skin Score and Skin Score Change
Abstract Number: 2928

Serum IL-33 Level Is Increased in Rheumatoid Arthritis and Predicts Response to Rituximab in Combination with High Serum IgG Level and Autoantibody Positivity: An Open-Label, Prospective, Multicentre Biological Trial
Abstract Number: 2582

Serum Levels of Bone Morphogenetic Protein-7 and Sclerostin Are Elevated in Ankylosing Spondylitis, but Not Linked with Structural Damage
Abstract Number: 1715

Serum Levels of CD163/Tweak Predict Risk of Digital Ulcers in Patients with Systemic Sclerosis
Abstract Number: 2925

Serum MMP-3 Predicts a Subgroup with No Radiographic Progression in Rheumatoid Arthritis Patients with Low-Dose Methotrexate (MTX) Monotherapy
Abstract Number: 2661

Serum Neuronal Biomarkers and Brain Atrophy in Childhood-Onset Systemic Lupus Erythematosus
Abstract Number: 2515

Serum Survivin in Early Rheumatoid Arthritis
Abstract Number: 1221

Serum Uric Acid As an Independent Risk Factor on Progression of Chronic Kidney Disease in Gout Patients with Uric Acid Lowering Agent
Abstract Number: 129

Seven Joints Ultrasound Scoring System May be Useful and Effective in Assessing Disease Activity in Patients with Rheumatoid Arthritis in the State of Remission in Daily Clinical Practice
Abstract Number: 2158

Severe Neutropenia in Patients with Rheumatic Diseases at a Tertiary Care Hospital in South Korea
Abstract Number: 62

Severe Spine Osteoarthritis in Older Men Is Associated with the Risk of Incident Fragility Fracture
Abstract Number: 2943

Severity of Foot Pain Is Linked to the Prevalence of Depressive Symptoms: The Framingham Foot Study
Abstract Number: 189

Sex Differences in Characteristics, Utilization and Outcomes of Patient Undergoing Total Elbow Arthroplasty: A Study of the U.S. Nationwide Inpatient Sample
Abstract Number: 1072

Sex Ratio of Offspring Born to Women with Lupus and Rheumatoid Arthritis
Abstract Number: 1974

Sex Steroids, Interleukin-1, and Interleukin-10 Inhibit interferon–gamma (IFN-γ) Induced B Cell Activating Factor of the Tumor Necrosis Factor Family (BAFF) in Human Synovial Fibroblasts
Abstract Number: 2818

SH2 Domain-Containing Phosphatase 2 Promotes Aggressiveness of Rheumatoid Fibroblast-like Synoviocytes
Abstract Number: 617

Shared HLA Class I and II Alleles in Susceptibility to Ankylosing Spondylitis Among Three Ethnic Groups
Abstract Number: 2738

Shk-186, a Kv1.3 channel inhibitor That Targets Effector Memory T Cells: Safety and Tolerability in Humans and Its Evaluation in a Model of Rapidly Progressive Glomerulonephritis
Abstract Number: 2611

Short Term Efficacy of Tumor Necrosis Factor Inhibitors in Patients with non–radiographic Axial Spondylarthritis and ankylosing Spondylitis; Results from Turkbio Registry
Abstract Number: 1701

Short-Term Effects of Iloprost on Micro-Vessels Hemodynamics in Systemic Sclerosis Patients Evaluated By Laser Doppler Flowmetry
Abstract Number: 2603

Short-Term Non-Steroidal Anti-Inflammatory Drug (NSAID) Use Induces Subclinical-Kidney-Injury in Spondyloarthritis Patients: Urinary Biomarker Study
Abstract Number: 466

Should Anti-Tnfa treatment of RA be Stopped before Orthopedic Surgery?
Abstract Number: 2375

Should Physician Reduce patients’ Glucocorticoids to Offset the Risk of Serious Infection Event Among RA Patients Who Switched from Non-Biologic Dmards and Glucocorticoid to Biologics?
Abstract Number: 2739

SHP-1 Regulates the Activation Threshold of iNKT Cells
Abstract Number: 307

Sibling Exposure and Risk of Juvenile Idiopathic Arthritis
Abstract Number: 233

Significance of Serum Marker Levels of Wnt/ß-Catenin Signaling Pathway in Patients with Systemic Autoimmune Diseases Under Glucocorticoid Therapy; A Prospective Study
Abstract Number: 232

Significance of Serum Srankl and Osteoprotegerin Concentration in Patients with Rheumatoid Arthritis
Abstract Number: 2123

Significant State-Level Variation in Source of Biologic Drug Coverage Among Beneficiaries with Rheumatoid Arthritis
Abstract Number: 877

Sildenafil Attenuates the Fibrotic Phenotype in Scleroderma Skin Fibroblasts
Abstract Number: 2393

Similar Improvements in Physical Function, Quality of Life and Work Productivity Among Rheumatoid Arthritis Patients Treated with 2 Different Doses of Methotrexate in Combination with Adalimumab
Abstract Number: 2413

Similar Response Rates to Anti-Tumor Necrosis Factor and Non- Anti-Tumor Necrosis Factor Biologic Therapies in Ethnic Minority Patients at 6 Months
Abstract Number: 510

Similar Short Term Survival on Drug for Patients with Rheumatoid Arthritis Treated with Subcutaneous and Intravenous Abatacept – Results from the National Swedish Rheumatology Quality Register
Abstract Number: 2596

Similarities and Differences Between Axial and Peripheral Predominant Forms in patients with Early Spondyloarthritis (SpA): Results from the Esperanza Cohort
Abstract Number: 716

Simple Disease Assessment for People with Lupus Erythematosus
Abstract Number: 1987

Simulation in Continuing Education: Improving Evidence-Based Decisions for Rheumatoid Arthritis Management
Abstract Number: 1617

Single Cell Interferon Signatures in Lupus Patient Monocytes Reveal a Differential Impact of Interferon Signaling Between Monocyte Subtypes
Abstract Number: 284

Single Hub and Access Point for Paediatric Rheumatology in Europe (SHARE)– Evidence Based Recommendations for Diagnosis and Treatment of Juvenile Idiopathic Arthritis
Abstract Number: 1325

Single Hub and Access Point for Pediatric Rheumatology in Europe (SHARE): Evidence Based Recommendations for Diagnosis and Treatment of Juvenile Localized Scleroderma and Juvenile Systemic Sclerosis
Abstract Number: 2540

Sjö™, an Advanced Diagnostic Panel for Detection of Sjögren’s Syndrome Autoantibodies
Abstract Number: 1091

Skeletal Muscle Fat and Its Association with Physical Function and Physical Activity in Adults with Rheumatoid Arthritis
Abstract Number: 964

Skin Collagen Synthesis Rates Distinguish Between Early and Late Diffuse Scleroderma Patients
Abstract Number: 2843

SLE Patients Carrying a Disease-Associated PTPN22 R620W Variant Show Reduced Interferon-Inducing Capacity
Abstract Number: 172

Sleep Apnea and Risk of Incident Gout: A Population-Based Body-Mass Index Matched Cohort Study
Abstract Number: 570

Sleep Disturbances in Korean Patients with Ankylosing Spondylitis Are Associated with Increased Disease Activity
Abstract Number: 2833

SM101, a Novel Recombinant, Soluble, Human FcγIIB Receptor, in the Treatment of Systemic Lupus Erythematosus: Results of a Double-Blind, Placebo-Controlled Multicenter Study
Abstract Number: 894

Small Fiber Neuropathy in Women with Fibromyalgia. a Clinical-Pathological Correlation Using Confocal Corneal Biomicroscopy
Abstract Number: 2524

Smoking and Response to Rituximab in Anti-CCP Positive and Negative Rheumatoid Arthritis – Results from an International European Collaboration
Abstract Number: 435

Smoking Functions As a Negative Regulator of IGF-1 Levels and Adipokine Network in Patients with Rheumatoid Arthritis
Abstract Number: 2584

Smoking Is Not Associated with Response to TNF Blockers in Patients with Axial Spondyloarthritis
Abstract Number: 348

Smoking Status Is Associated with Inflammatory Cytokine Profile and Disease Activity: Decreased Inflammation and Disease Improvement with Smoking Cessation?
Abstract Number: 1068

Smoking-Related Mortality in Rheumatoid Arthritis: A Retrospective Cohort Study Using Electronic Medical Records
Abstract Number: 2167

Snapin Is Critical for Cathepsin D Activation and the Normal Lysosomal Function
Abstract Number: 1334

Social Support and Suicidal Ideation in Systemic Lupus Erythematosus: Georgians Organized Against Lupus Cohort
Abstract Number: 2120

Societal Preferences for Rheumatoid Arthritis Treatments. Evidence from a Discrete Choice Experiment
Abstract Number: 1088

Socioeconomic Disparities in Health Outcomes Among Individuals with, or at Risk for, Osteoarthritis from the United States: Data from the Osteoarthritis Initiative
Abstract Number: 978

Socioeconomic Status Measures Are Associated with Increasing Pain, Stiffness and Physical Function Among Individuals with Knee and Hip Osteoarthritis
Abstract Number: 366

Soluble 4-1BB Is a Marker of Joint Involvement and Disease Activity in Rheumatoid Arthritis
Abstract Number: 409

Soluble CD163 Is a Marker of Disease Activity in Early Rheumatoid Arthritis and Reflects TNFα Levels
Abstract Number: 388

Soluble TREM-1 Is a Biomarker of Anti-CCP-Positive, DMARD-Naive Early Rheumatoid Arthritis
Abstract Number: 144

Sonographic Differentiation of Heel Pain: Focal Degenerative Versus Systemic Inflammatory Enthesitis
Abstract Number: 119

Sonographic Evaluation of the Fifth Metatarsophalangeal Joint Erosion in Rheumatoid Arthritis
Abstract Number: 151

Sonographic Measurements Can be Misleading for Diagnosing Carpal Tunel Syndrome in Patients with Rheumatoid Arthritis
Abstract Number: 761

Specific Autoantibody Profiles and Disease Subgroups Correlate with Circulating Micro-RNA in Systemic Sclerosis
Abstract Number: 2346

Specific Overexpression of FPR2(FPRL-1) on Th1 Cells in GPI-Induced Arthritis and Patients with Rheumatoid Arthritis
Abstract Number: 867

Specific SLE Disease Manifestations in the Six Months Prior to Conception Predict Similar Manifestations during Pregnancy
Abstract Number: 2566

Spinal Mobility in the Cervical and the Lumbar Spine Correlates with Magnetic Resonance Imaging Findings in Patients with Ankylosing Spondylitis
Abstract Number: 63

Spine Osteoarthritis Is Associated with All Cause Mortality in Older Men
Abstract Number: 53

Spine-Hip Diagnostic Discordance in the United Arab Emirates
Abstract Number: 1450

Spironolactone As a Novel DMARD in Rheumatoid Arthritis
Abstract Number: 710

Splenectomy in Systemic LUPUS Erythematosus and AUTOIMMUNE Hematological Diseases. a Comparative Analysis
Abstract Number: 2829

Spondyloarthritis Is Associated with Increased Cardiovascular and Cerebrovascular Mortality
Abstract Number: 1398

Spontaneous Regression of Methotrexate (MTX)-Related Lymphoproliferative Disorder Correlates with Lymphocyte Restoration after MTX Withdrawal
Abstract Number: 443

Sputum Anti-Citrullinated Protein Antibodies in Patients with Long Standing Rheumatoid Arthritis
Abstract Number: 1761

Standardisation of Disease Assesment in Systemic Vasculitis: Use of a Novel Web-Based Software Training Application
Abstract Number: 1858

Standardized Mortality Ratios for Cause-Specific Deaths in Lupus Patients Followed Prospectively at a Single Centre Lupus Clinic
Abstract Number: 2319

Standardizing and Documenting Patient Education and Disease Indices in Childhood-Onset Systemic Lupus Erythematosus
Abstract Number: 1777

Staphylococcus Aureus Nasal Carriage and Relapses, Bvas, ANCA-Positivity and Cotrimoxazole Use in ANCA-Associated Vasculitis
Abstract Number: 663

STAT3 Inhibition Delays the Onset of Lupus Nephritis in MRL/Lpr Mice
Abstract Number: 1033

Stat3 Promotes IL-10 Expression in SLE T Cells through Trans-activation and Chromatin Remodeling
Abstract Number: 1815

STAT3-Mediated Regulation of Mitochondrial Membrane Potential Is Critical for NLRP3 Inflammasome Activation
Abstract Number: 3009

Stem Cell Augmentation for Cardiovascular Risk in Rheumatoid Arthritis
Abstract Number: 1457

Stem Cell Growth Factor Expression in Rheumatoid Arthritis
Abstract Number: 2283

Steroid-Sparing Effect of Anakinra (Kineret^®) in the Treatment of Patients with Severe Cryopyrin-Associated Periodic Syndrome
Abstract Number: 33

Stimulation of the Adenosine a_2Areceptor (A2AR) Regulates the Expression of Netrin1 and Their Receptors (Unc5b, DCC) and Inhibits Osteoclast Differentiation and Inflammatory Bone Destruction
Abstract Number: L21

Striking Discrepancy in the Development of Anti-Drug Antibodies (ADA) in Patients with Rheumatoid Arthritis (RA) and Ankylosing Spondylitis (AS) in Response to Infliximab (INF) and Its Biosimilar CT-P13
Abstract Number: 2468

Stringent Criteria for Low Disease Activity and Remission after 12 Months of Treatment, and after Treatment Withdrawal, with Abatacept Monotherapy, Abatacept with Methotrexate or Methotrexate Alone in Early Rheumatoid Arthritis
Abstract Number: 1080

Stroke Risks Among U.S. Medicaid Recipients with Systemic Lupus Erythematosus, 2000-2006: Racial and Ethnic Variation
Abstract Number: 2463

Stromal Cell Markers Are Differentially Expressed in the Synovial Tissue of Patients with Early Arthritis
Abstract Number: 1916

Stromal Overexpression of Transmembrane TNF Induces Spa-like Arthritis and Spondylitis in Mice
Abstract Number: 566

Structural Progression of the Spine Measured By X-Ray in Patients with Axial Spondyloarthritis Treated with Certolizumab Pegol over 96 Weeks, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis
Abstract Number: 1997

Structured Integrative Rheumatology Modules (SIRM)
Abstract Number: 1379

Studies on Ageing and the Severity of Radiographic Joint Damage in Rheumatoid Arthritis
Abstract Number: 1268

Study of Autoantibodies in a cohort of Mexican patients with idiopathic inflammatory myopathies
Abstract Number: 1533

Study of One Vial (400mg) per Body Infusion of Tocilizumab in Patients with Active Rheumatoid Arthritis
Abstract Number: 1226

Studying Patients with Autoinflammatory Diseases: The Past, Present, and a Perspective for the Future
Abstract Number: 1381

Subaxial Cervical Spine Involvement in Symptomatic Rheumatoid Arthritis Patients: Comparison with Cervical Spondylosis
Abstract Number: 1818

Subchondral Bone Mineral Density Improves Prediction of Knee Osteoarthritis Progression Compared with Clinical Factors Alone: Data from the Osteoarthritis Initiative
Abstract Number: 2127

Subclinical Arthritis Is Detected By Macrophage Targeting and Positron Emission Tomography (PET) in Early RA Patients in Clinical Remission
Abstract Number: 1184

Subclinical Inflammation in Psoriatic Patients with No History of Psoriatic Arthritis: An Assessment By Magnetic Resonance Imaging
Abstract Number: 1300

Subclinical Right Ventricle Systolic Dysfunction By Two-Dimensional Speckle-Tracking Echocardiography in Childhood-Onset Systemic Lupus Erythematosus Patients
Abstract Number: 152

Subclinical Synovial Inflammation in Gout
Abstract Number: 1893

Substantial Structural Lesions on MRI in the Sacroiliac Joints of Patients with Non-Radiographic Axial Spondyloarthritis Even in the Absence of MRI Inflammation
Abstract Number: 2192

Successful Therapy with Intravenous Sodium Thiosulfate for Adult Dermatomyositis Associated Calcinosis
Abstract Number: 685

Successful Withdrawal and Discontinuation of Immunosuppressants in Lupus Patients: Outcomes and Predictors
Abstract Number: 1954

Successfull Long-Term Depletion of Memory Plasma Cells Requires a Combined Depletion of Plasma Cells and Their Precurors in NZB/W Mice
Abstract Number: 322

Superior Therapeutic Efficacy of a Novel Oral Small Molecule Retinoic Acid Receptor-Related Orphan Receptor Gamma T [Rorgt] Inverse Agonist Inv-17: A Promising Safe & Efficacious Treatment for Rheumatoid Arthritis
Abstract Number: 1618

Suppression of IFN-α Production from Systemic Lupus Erythematosus Immune Complexes Via C1 Complex Enzymatic Properties
Abstract Number: 1222

Suppressive Effect of Butyrate on Monosodium Urate (MSU) Crystal-Induced IL-1beta Production Is Mediated Via Inhibition of Class I Histone Deacetylases
Abstract Number: 218

Surface Area and Fatty Infiltration of Vastus Medialis Measured By Magnetic Resonance Imaging Are Risk Factors for the Progression of Knee Osteoarthritis and Discriminate Two Osteoarthritis Phenotypes
Abstract Number: 2106

Surgical Compared with Nonsurgical Management of Fractures in Men with Chronic Spinal Cord Injury
Abstract Number: 2995

Surrogate Measures of Extent of Interstitial Lung Disease As Measured By Quantitative Radiographic Analysis in Patients with Systemic Sclerosis
Abstract Number: 2698

Survival in Systemic Sclerosis-Pulmonary Arterial Hypertension By Serum Autoantibody Status
Abstract Number: 1785

Survival of Microscopic Polyangiitis (MPA) Patients with and without Pulmonary Fibrosis (PF)
Abstract Number: 2847

Survivin Co-Ordinates Formation of Follicular T-Cells in Rheumatoid Arthritis
Abstract Number: 1538

Sustained Clinical Benefit with Multiple Courses of Rituximab in Second LineÂ forÂ All Rheumatoid Arthtritis PatientsÂ Irrespective to the Inhibitor of Tumour Necrosis FactorÂ Previously Used
Abstract Number: 1526

Sustained Clinical Efficacy after Multiple Courses of Rituximab in Rheumatoid Arthritis Patients with Inadequate Response to Tumor Necrosis Factor Inhibitors: 3-Year DataÂ
Abstract Number: 552

Sustained Improvement in Physical Function, Health-Related Quality of Life, and Work Productivity with Adalimumab Treatment in Non-Radiographic Axial Spondyloarthritis
Abstract Number: 1521

Sustained Improvements in Magnetic Resonance Imaging Outcomes with Abatacept Following the Withdrawal of All Treatment in Patients with Early Rheumatoid Arthritis
Abstract Number: 2560

Sustained Improvements in Workplace and Household Productivity and Social Participation with Certolizumab Pegol over 96 Weeks in Patients with Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis
Abstract Number: 1552

Sustained Improvements in Workplace and Household Productivity and Social Participation with Certolizumab Pegol over 96 Weeks in Patients with Psoriatic Arthritis
Abstract Number: 11

Sustained Moderate Intensity Levels of Oral Anticoagulant Therapy and the Rate of Recurrent Thrombosis in Patients with Primary Antiphospholipid Syndrome
Abstract Number: 2394

Sustained Remission Improves Physical Function in RA Patients Treated with Tumor Necrosis Factor Inhibitor
Abstract Number: 2391

Sustained Rheumatoid Arthritis Remission and Low Disease Activity: Analysis of 13 Years of Follow up in Clinical Practice
Abstract Number: 1242

Switching Biologic Agents in Refractory Adult-Onset Still’s Disease: Efficacy and Safety in a Cohort of 20 Patients at a Single Referral Center
Abstract Number: 2271

Symptom and Treatment Characteristics of Juvenile Primary Fibromyalgia Syndrome: Are Males and Females Created Equal?
Abstract Number: 892

Symptom Increase in Fibromyalgia Is Not Consistent with the Central Sensitization or Central Hyperresponsiveness Hypothesis
Abstract Number: 2951

Syndecan-4 Regulates Chondrocyte Phenotype and Cartilage Homeostasis Via the WNT Signaling Pathway
Abstract Number: 1036

Synergism Between GM-CSF and IL-17 Causes Enhanced Joint Pathology Via the Production of IL-6 and IL-23
Abstract Number: 1472

Synovial Fluid from Rheumatoid Arthritis Patients Modulates the Immunophenotype and Viability of Monocytes
Abstract Number: 2950

Synovial Macrophages Promote TGF-β Activation after Intra-Articular Injections of Oxidized LDL in Naïve Murine Knee Joints, Preventing Production of Pro-Inflammatory Factors S100A8/9, Chemokines and Aggrecanase-Induced Neo-Epitopes
Abstract Number: 1292

Synovitis Characteristics and Associated Intra-Articular Pathology in a Cohort of Patients Undergoing Meniscectomy for Meniscal Tear
Abstract Number: 1100

System Review: The Most Common Symptoms of Fibromyalgia Patients Other Than Pain, Fatigue, Insomnia, and Cognitive Dysfunction
Abstract Number: 2044

Systematic Review of the Effect of Anti-Rheumatic Therapies upon Vaccine Immunogenicity
Abstract Number: 2906

Systemic Delivery of Short Hairpin RNA Targeting Calcium Release-Activated Calcium Channel 3 Down-Regulates Severity of Collagen-Induced Arthritis
Abstract Number: 1429

Systemic Inflammation in Alzheimer’s Disease: Relevance to Patients with Rheumatoid Arthritis
Abstract Number: 2779

Systemic Inflammatory and Autoimmune Manifestations Associated with Myelodysplastic Syndrome: A French Multicenter Retrospective Study
Abstract Number: 319

Systemic Juvenile Idiopathic Arthritis and Exposure to Fine Particulate Air Pollution
Abstract Number: 2669

Systemic Lupus Erythematosus and Lactation: Factors Affecting Infant Feeding Choices in Women with SLE
Abstract Number: 2622

Systemic LUPUS Erythematosus in Spanish Males
Abstract Number: 1854

Systemic Lupus Erythematosus Patients Have Increased Risk of Short Term Adverse Events after Total Hip Arthroplasty
Abstract Number: 1282

Systemic Pain Modulation Is Related to Body Perception in People with Knee Osteoarthritis
Abstract Number: 747

Systemic Sclerosis Patients with Antitopoisomerase Antibodies Showed Significant Association with CCR6 Polymorphisms
Abstract Number: 1691

Systemic Sclerosis Patients with Pulmonary Hypertension Have a Lower Change in End Tidal Carbon Dioxide Following Three Minutes of Step Exercise Than Systemic Sclerosis Patients without Pulmonary Hypertension: A Cross-Sectional Study
Abstract Number: 2707

Systemic Sclerosis Related Calcinosis: Patients Provide What Specialists Want to Learn
Abstract Number: 2226

Systemic Treatment for Clinically Amyopathic Dermatomyositis